Navigation Links
News from Cancer


Doctors at the University of Kentucky Chandler Medical Center-Markey Cancer Center compared symptom analysis to ultrasound in predicting ovarian cancer. They selected 272 women participating in annual trans-vaginal screening (TVS) from 31,748 women enrolled in a free screening project at the university, comparing symptom results to ultrasound and surgical pathology findings. They found TVS performed better than symptoms analysis for detecting malignancies (73.3% versus 20% sensitivity). While symptoms analysis performed better for distinguishing benign tumors (91.3% versus 74.4% specificity), adding symptom analysis to TVS actually resulted in poorer identification of malignancy (sensitivity = 16.7%), even as it improved the ability to distinguish benign tumors (specificity = 97.9%). The authors say the data indicates that while symptoms do identify ovarian malignancies, they are not as accurate as TVS. They add that informative symptoms can be expected to be absent in 80 percent of ovarian malignancies.

Article: "The Search for Meaning --- Symptoms & TVS Screening." Edward J. Pavlik, Brook A. Saunders, Stacey Doran, Katherine W. McHugh, Frederick R. Ueland, Christopher P. DeSimone, Paul D. DePriest, Rachel A. Ware, Richard J. Kryscio, and John R. van Nagell, Jr. CANCER; Published Online: July 13, 2009 (DOI: 10.1002/cncr.24407); Print Issue Date: August 15, 2009

Contact: Keith L. Hautala, University of Kentucky Public Relations, Phone: (859) 323-6363 EXT. 231 or

Editorial: "The search for meaning---symptoms and TVS screening for ovarian cancer Silent no more." Ilana Cass, M.D. CANCER; Published Online: July 13, 2009 (DOI: 10.1002/cncr.24403); Print Issue Date: August 15, 2009


Colorectal cancer (CRC) is the third leading cause of cancer death in both men and women and the second leading cause of cancer death when both sexes are combined. African Americans have lower survival rates compared to whites. Researchers at Barbara Ann Karmanos Cancer Institute, in Detroit, Michigan in Detroit sought to investigate the effect of demographics, clinical factors and socioeconomic status (SES) on racial disparities in CRC survival in the Detroit Metropolitan Area. The study population included 9,078 individuals with primary invasive CRC identified between 1988 and 1992 through the Surveillance, Epidemiology, and End Results (SEER) program. They found African Americans were more likely to be diagnosed with stage IV disease and to reside within poor census tracts compared to whites. After adjusting for age, marital status, gender, SES group, stage, and treatment, race was no longer significantly associated with overall survival. Similar results were seen with CRC-specific survival. They conclude racial disparities in CRC survival dissipate after adjusting for other demographic and clinical factors. These results can potentially affect medical guidelines regarding screening and treatment, and possibly influence public health policies that can have a positive impact on equalizing racial differences in access to care.

Article: "Racial Differences in Colorectal Cancer Survival in the Detroit Metropolitan Area." Ben Yan, Anne-Michelle Noone, Cecilia Yee, Mousumi Banerjee, Kendrea Schwartz, and Michael S. Simon. CANCER; Published Online: July 13, 2009 (DOI: 10.1002/cncr.24408); Print Issue Date: August 15, 2009

Contact: Patricia Ellis, Manager, Media Relations Karmanos Cancer Institute, 313-576-8629 office, 313-410-3417 mobile, or


Studies have reported an increasing incidence of thyroid cancer since 1980. One possible explanation for this trend is increased detection through more widespread and aggressive use of screening tests. Researchers at the American Cancer Society analyzed thyroid cancer incidence between 1988 and 2005 using the National Cancer Institute's (NCI's) Surveillance Epidemiology and End Results (SEER) dataset. They found incidence rates increased for all sizes of tumors, suggesting that screening is not the only explanation for the rise. The highest rate of increase was for primary tumors smaller than 1.0 cm, which rose nearly 10 percent per year among men from 1997 and 2005, and nearly 9 percent/year from 1988 to 2005 among women. Incidence of tumors 4 cm or larger increased more than 3.5 percent per year from 1988 to 2005 among men and 5.7 percent per year from 1988 to 2005 among women. The authors conclude that incidence rates of differentiated thyroid cancers of all sizes increased between 1988 and 2005 in both men and women, and that the increased incidence across all tumor sizes suggests that increased detection through testing is not the sole explanation. Other explanations, including environmental influences and molecular pathways, should be investigated.

Article: "Increasing Incidence of Differentiated Thyroid Cancer in the US (1988-2005)." Amy. Y. Chen, Ahmedin Jemal, and Elizabeth M. Ward. CANCER; Published Online: July 13, 2009 (DOI: 10.1002/cncr.24416); Print Issue Date: August 15, 2009

Contact: David Sampson, American Cancer Society,


Current research is inconclusive regarding the relationship between alcohol consumption and prostate cancer risk. Researchers led by Zhihong Gong Ph.D. of the University of California San Francisco, examined the associations of total alcohol, type of alcoholic beverage, and drinking pattern with risks of total, low- and high-grade prostate cancer. They used data from more than 10,000 men participating in the Prostate Cancer Prevention Trial (PCPT). They found participants who reported heavy alcohol consumption (≥50 g alcohol/day) and regular heavy drinking (≥4 drinks/day on ≥5 days per week) were twice as likely or more to be diagnosed with high-grade prostate cancer (RR: 2.01, and 2.17, respectively). Less heavy drinking was not associated with risk. They also compared drinking patterns with treatment outcome among men enrolled on this placebo-controlled trial of the drug finasteride. They found finasteride's ability to lower prostate cancer risk was blocked in men drinking < 50g alcohol per day. They conclude heavy, daily drinking increases the risk of high-grade prostate cancer and that heavy drinking made finasteride ineffective for reducing prostate cancer risk.

Article: "Alcohol Consumption, Finasteride and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial." Zhihong Gong, Alan R. Kristal, Jeannette M. Schenk, Catherine M. Tangen, Phyllis J. Goodman, and Ian M. Thompson. CANCER; Published Online: July 13, 2009 (DOI: 10.1002/cncr.24423); Print Issue Date: August 15, 2009

Contact: Kristen Lidke Woodward, Senior Media Relations Manager, Fred Hutchinson Cancer Research Center. Phone: 206-667-5095, Email:


Contact: David Sampson
American Cancer Society

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Comfort ... the American Cancer Society and the Road To Recovery® program to drive cancer patients ... seniors and other adults to ensure the highest quality of life and ongoing independence. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
Breaking Medicine Technology: